Riken Vitamin Co., Ltd.
4526.T
Get informed when a big investor buys or sells
+ FollowMarket Cap$91.5B
Close$
Share Statistics
| Market cap | $91.50 Billion |
|---|---|
| Enterprise Value | $81.00 Billion |
| Dividend Yield | $110.00 (3.51%) |
| Earnings per Share | $238.17 |
| Beta | 0.01 |
| Outstanding Shares | 29,137,224 |
Return
| Return on Equity | 8.39% |
|---|---|
| Return on Assets | 6.03% |
| Return on Invested Capital | 7.19% |
Valuation & Multiples
| P/E Ratio | 13 |
|---|---|
| PEG | 539.21 |
| Price to Sales | 0.93 |
| Price to Book Ratio | 1.08 |
| Enterprise Value to Revenue | 0.83 |
| Enterprise Value to EBIT | 11.42 |
| Enterprise Value to Net Income | 11 |
| Total Debt to Enterprise | 0.09 |
| Debt to Equity | 0.09 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 7, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$23.50 B
Average shareholder expectationNext Earnings Call
Expected Date
November 12, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$25.97 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Riken Vitamin Co., Ltd.
1,887 employees
CEO: Atsushi Mochizuki Riken Vitamin Co., Ltd., based in Tokyo, Japan, operates across several key sectors: food ingredients, food applications, healthcare, and chemicals. The company provides a diverse portfolio of food additives, including emulsifiers used i...